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Sex differences in addiction	

§  Women display markedly faster progressions from casual drug 
use to drug abuse and addiction relative to men	

§  Female sex steroid, estradiol, appears to mediate this effect	

Neural mechanisms of estradiol	

§  Striatum is an integral brain region in development and 
expression of addictive behaviors 	

§  Estradiol can impact striatal function via multiple mechanisms:	

§  Activation of membrane localized estrogen 
receptors coupled to mGluR5	

§  Stimulation of the endocannabinoid system via 
mGluR5	

Does estradiol modulate expression of components of the 
endocannabinoid system within the striatum to drive addictive 
behavior in females? If so, does this effect of estradiol occur via 
mGluR5?	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

	

We hypothesized that estradiol mediates the expression of 
molecules that synthesize, degrade, and bind the two best 
studied endocannabinoids in the striatum (2AG and AEA) via 
mGluR5, to ultimately drive addictive behaviors in females. 	
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§  Directly measure endocannbinoid levels within striatum	

§  Determine whether this action of estradiol is genomic, non-genomic or 
both	

§  Investigate endocannabinoid synthesis, degradation and binding in male 
brain	

CONCLUSIONS 
FUTURE DIRECTIONS 
§  Estradiol enhances the expression of endocannabinoid synthesizing 
enzymes in the caudate putamen	

§  This effect occurs via mGluR5	

§  Estradiol enhances the expression of the cannabinoid receptor in the 
nucleus accumbens	

§  This effect occurs via mGluR5	

§  Estradiol does not affect the expression of endocannabinoid 
degrading enzymes in the striatum	

§  Estradiol may increase endocannabinoid levels and 
endocannabinoid binding to cannabinoid receptors within the 
striatum and this may play a role in female responses to drugs 	

In the caudate putamen, estradiol treatment increases expression of 
endocannabinoid synthesizing enzyme DAGL, but does not affect expression of 
endocannabinoid degrading enzymes (MAGL, FAAH) or endocannabinoid 
receptor CB1. In the nucleus accumbens estradiol increases expression of the 
endocannabinoid receptor CB1, but has no effect on synthesizing or degrading 
enzymes.*p<0.05	

RESULTS 
MODEL 
METHODOLOGY 
In the caudate putamen, blocking mGluR5 attenuates the estradiol mediated 
increase in expression of endocannabinoid synthesizing enzyme DAGL. In the 
nucleus accumbens blocking mGluR5 attenuates the estradiol mediated increase 
in expression of the endocannabinoid receptor CB1.*p<0.05	
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